News | September 24, 2013

Visicoil fiducial marker is pre-loaded in 21 and 22 gauge thin needle to aid in percutaneous/transthoracic placement


September 24, 2013 — IBA (Ion Beam Applications S.A.) has launched an extension to the Visicoil product line at the annual ASTRO congress of the American Society for Radiation Oncology. This new design incorporates kV X-ray imaging compliant Visicoil Linear Markers pre-loaded in 21 and 22 gauge needles that are almost half the size of needles typically used for placement of gold seeds.

Compared to typical gold seeds, this new design enhances the ability of interventional radiology to safely and efficiently implant Visicoil markers, which subsequently supports radiation oncologists in highly precise patient setup and dose delivery during radiation therapy.

This new solution offers clinical benefits associated with smaller needles, such as increased patient safety and improved patient comfort. IBA’s patented Visicoil linear fiducial markers are an important component in the effort to increase targeting accuracy in radiation therapy applications such as stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), CyberKnife and proton therapy.

For more information: www.visicoil.com

 


Related Content

News | Radiation Oncology

February 7, 2023 — During World Cancer Day (February 4), the Elekta Foundation celebrated its first year by highlighting ...

Time February 07, 2023
arrow
News | Radiation Oncology

February 7, 2023 — Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer ...

Time February 07, 2023
arrow
News | Radiation Therapy

February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time February 06, 2023
arrow
Feature | ASTRO | Christine Book

The Imaging Technology News (ITN) editorial team is pleased to present the second portion of the American Society for ...

Time January 13, 2023
arrow
News | Proton Therapy

January 13, 2023 — RaySearch Laboratories AB announces that The Ohio State University Comprehensive Cancer Center - ...

Time January 13, 2023
arrow
News | Proton Therapy

January 9, 2023 — RaySearch Laboratories AB announced that CGN Medical Technologies has in December 2002 placed an order ...

Time January 08, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As 2022 comes to a close, the Imaging Technology News team takes a look at the year's most viewed content. Here is a ...

Time January 02, 2023
arrow
News | Linear Accelerators

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full ...

Time December 30, 2022
arrow
News | Breast Imaging

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

Time December 29, 2022
arrow
News | Radiation Therapy

December 22, 2022 — Patients with cancer that has spread to the bone are sometimes treated with alpha particle radiation ...

Time December 22, 2022
arrow
Subscribe Now